Accessible Search Form           Advanced Search

Skip left side navigation and go to content

Health Professionals

14. Inflammatory Markers

Because inflammation is an important part of the atherosclerotic process in adults, it was included as an independent risk factor for the evidence review, with specific inflammatory markers identified as outcome measures, as outlined in Appendix A. Methodology. No systematic reviews, meta-analyses, or randomized controlled trials (RCTs) that addressed inflammation in children or adolescents were identified. A small number of RCTs and observational studies included measurement of selected inflammatory markers, and these were reviewed. The Expert Panel concluded that the available evidence was not sufficient either to make any statement regarding the role of inflammation in atherosclerosis, as assessed by measurement of inflammatory markers in childhood, or to include any recommendation regarding measurement of inflammatory markers in the pediatric age group.

Back to Top

Back to Table of Contents

Twitter iconTwitterimage of external icon Facebook iconFacebookimage of external icon YouTube iconYouTubeimage of external icon Google+ iconGoogle+image of external icon